Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9 USD | +6,51% | +6,38% | +20,81% |
Omzet 2022 | 4,81 mln. 4,52 mln. | Omzet 2023 | 2,13 mln. 2,01 mln. | Marktkapitalisatie | 13,57 mln. 12,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -113 mln. -106 mln. | Nettowinst (verlies) 2023 | -62 mln. -58,25 mln. | EV/omzet 2022 | -17,6 x |
Nettoliquiditeiten 2022 | 96,61 mln. 90,77 mln. | Nettoliquiditeiten 2023 | 57,06 mln. 53,62 mln. | EV/omzet 2023 | -20,4 x |
K/w-verhouding 2022 |
-0,11
x | K/w-verhouding 2023 |
-0,22
x | Werknemers | 99 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 91,69% |
Recentste transcriptie over Talis Biomedical Corporation
1 dag | +6,51% | ||
1 week | +6,38% | ||
Lopende maand | +2,86% | ||
1 maand | -2,70% | ||
3 maanden | +10,29% | ||
6 maanden | +69,53% | ||
Lopend jaar | +20,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 01-09-20 |
Director of Finance/CFO | 51 | 01-01-22 | |
Kim Popovits
BRD | Director/Board Member | 65 | 31-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 01-03-16 |
Randal Scott
BRD | Director/Board Member | 66 | 01-01-14 |
Kim Popovits
BRD | Director/Board Member | 65 | 31-07-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 9 | +6,51% | 7 693 |
17-04-24 | 8,45 | -0,23% | 24 337 |
16-04-24 | 8,47 | -0,24% | 970 |
15-04-24 | 8,49 | -0,12% | 20 446 |
12-04-24 | 8,5 | +0,47% | 11 374 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+20,81% | 15,4 mln. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |